StockDrifts LogoStockDrifts

ABL BIO 298380

Company
에이비엘바이오ABL BIO
Insiders
1
Buys
3
Total Value
₩10M ($7K)
Avg Return
+1075.49%
Last Filing
2025-09-09

ABL BIO (298380) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩10M ($7K) in reported transaction value. The earliest filing StockDrifts holds for ABL BIO is dated 2023-01-05; the most recent is 2025-09-09. Across these filings the average return since disclosure is +1075.49%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-09-09BUY주식매수청구권 행사
김정대
Kim Jeong-dae
vice president50.0K₩103,000+84.0%₩5.2B ($3.6M)
2025-09-09BUY주식매수청구권 행사
원종화
Won Jong-hwa
vice president41.0K₩103,000+84.0%₩4.2B ($2.9M)
2025-02-27BUY주식매수청구권 행사
이재천
Jaecheon Lee
vice president17.2K₩41,200+359.9%₩708M ($491K)
2025-02-05SELL증여
LEESANGHOON
CEO-10.0K₩38,200-396.1%₩382M ($265K)
2024-11-05BUY주식매수선택권
원종화
Won Jong-hwa
vice president5.0K₩37,000+412.2%₩185M ($128K)
2023-10-27BUYMarket Buy
원종화
Won Jong-hwa
vice president40₩16,150+1073.4%₩646K ($449)
2023-10-25BUYMarket Buy
원종화
Won Jong-hwa
vice president274₩15,870+1094.1%₩4M ($3K)
2023-10-24BUYMarket Buy
원종화
Won Jong-hwa
vice president300₩16,350+1059.0%₩5M ($3K)
2023-01-05SELL증여
LEESANGHOON
CEO-25.0K₩22,500-742.2%₩563M ($391K)

Frequently asked questions

Who has been buying ABL BIO stock?
1 distinct insiders have filed 3 disclosed insider purchases in ABL BIO (298380), most recently on 2025-09-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does ABL BIO have?
ABL BIO has 3 buy-side and 0 sell-side disclosures on record, covering ₩10M ($7K) in total reported value, spanning 2023-01-05 to 2025-09-09.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.